Nuveen’s Lunai Bioworks LNAI Stock Holding History

Nuveen’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,896	Closed	-$82.4K	–	3388
2025 Q1	$82.4K	Hold	1,896	–	–	﹤0.01%	3230
2024 Q4	$127K	Buy	1,896 +1,067	+129%	+$70.8K	﹤0.01%	3272
2024 Q3	$32K	Hold	829	–	–	﹤0.01%	3330
2024 Q2	$116K	Buy	+829	New	+$113K	﹤0.01%	3300
2023 Q2	–	Sell	-1,519	Closed	-$111K	–	3277
2023 Q1	$111K	Sell	1,519 -38	-2%	-$3.34K	﹤0.01%	3050
2022 Q4	$128K	Sell	1,557 -207	-12%	-$27.8K	﹤0.01%	3088
2022 Q3	$255K	Buy	1,764 +51	+3%	+$9.3K	﹤0.01%	3077
2022 Q2	$265K	Buy	+1,713	New	+$784K	﹤0.01%	3116
2021 Q2	–	Sell	-300	Closed	-$85K	–	3507
2021 Q1	$85K	Hold	300	–	–	﹤0.01%	3293
2020 Q4	$71K	Hold	300	–	–	﹤0.01%	3246
2020 Q3	$86K	Hold	300	–	–	﹤0.01%	3223
2020 Q2	$101K	Hold	300	–	–	﹤0.01%	3160
2020 Q1	$72K	Hold	300	–	–	﹤0.01%	3091
2019 Q4	$120K	Buy	+300	New	+$132K	﹤0.01%	3117

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Nuveen's LNAI Position: Q2 2025 in Review

Nuveen sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 1,896 shares — an estimated $82.4K sold.

Nuveen first reported a position in LNAI in Q4 2019 and held it in 14 quarters. The position peaked at $265K in Q2 2022. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

Nuveen reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
Nuveen sold 1,896 Lunai Bioworks shares in Q2 2025, an estimated $82.4K.
Nuveen first reported a position in Lunai Bioworks in Q4 2019 and held it in 14 quarters.
Nuveen's Lunai Bioworks position peaked at $265K in Q2 2022.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.